InHANSE Institute of Head and Neck Studies and Education Contact Us

New study open to recruitment

WISTERIA: A Phase I trial of WEE1 inhibition with Chemotherapy and Radiotherapy as adjuvant treatment, and a Window of Opportunity trial with Cisplatin in Patients with Head and Neck Cancer


We are delighted to announce that the WISTERIA Trial opened to recruitment yesterday at the Queen Elizabeth Hospital, Birmingham! We are aiming to enroll our first patient into the trial over the upcoming weeks

Charity appeal

Find out more about our £1m Charity appeal for the AcceleraTED cancer Treatment programme.